Abstract
Clinical depression is a common disorder observed in women of childbearing age, especially during pregnancy and postpartum. Venlafaxine, classified as a Serotonin and Norepinephrine Reuptake Inhibitor (SNRI), is one of the main options for the treatment of prenatal and postnatal depression. Since serotonin has an important role in the development of the central nervous system, in utero an…